Yoko Ogawara

862 total citations
14 papers, 591 citations indexed

About

Yoko Ogawara is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Yoko Ogawara has authored 14 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Yoko Ogawara's work include Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yoko Ogawara is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yoko Ogawara collaborates with scholars based in Japan, United Kingdom and United States. Yoko Ogawara's co-authors include Yukiko Gotoh, Shohei Kishishita, Toshiaki Suzuki, Keiji Tanaka, Toshiyuki Obata, Norihisa Masuyama, Issay Kitabayashi, Takuo Katsumoto, Yuki Kagiyama and Kazushi Araki and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Yoko Ogawara

12 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Ogawara Japan 6 445 213 118 56 52 14 591
Llorenç Coll-Mulet Spain 11 452 1.0× 263 1.2× 93 0.8× 52 0.9× 67 1.3× 12 663
Anchit Khanna Australia 10 512 1.2× 298 1.4× 92 0.8× 50 0.9× 58 1.1× 16 691
Daniela Di Marcantonio United States 15 417 0.9× 148 0.7× 66 0.6× 86 1.5× 31 0.6× 29 569
Joji Nakayama Japan 8 344 0.8× 222 1.0× 155 1.3× 30 0.5× 58 1.1× 16 602
Eyal Kalo Israel 9 464 1.0× 334 1.6× 157 1.3× 28 0.5× 102 2.0× 10 663
Susanne Radke United States 10 526 1.2× 204 1.0× 84 0.7× 33 0.6× 47 0.9× 11 695
Kristin M. Stadelman United States 9 465 1.0× 185 0.9× 158 1.3× 37 0.7× 55 1.1× 13 613
Kinga A. Kocemba‐Pilarczyk Poland 11 390 0.9× 170 0.8× 156 1.3× 143 2.6× 39 0.8× 24 570
Elena G. Chiorean United States 8 323 0.7× 143 0.7× 262 2.2× 39 0.7× 40 0.8× 18 643

Countries citing papers authored by Yoko Ogawara

Since Specialization
Citations

This map shows the geographic impact of Yoko Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Ogawara more than expected).

Fields of papers citing papers by Yoko Ogawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Ogawara. The network helps show where Yoko Ogawara may publish in the future.

Co-authorship network of co-authors of Yoko Ogawara

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Ogawara. A scholar is included among the top collaborators of Yoko Ogawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Ogawara. Yoko Ogawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Katsumoto, Takuo, Yoko Ogawara, Kazutsune Yamagata, et al.. (2022). MOZ is critical for the development of MOZ/MLL fusion–induced leukemia through regulation of Hoxa9/Meis1 expression. Blood Advances. 6(19). 5527–5537. 7 indexed citations
2.
Matsunaga, Hironori, Makoto Nakagawa, Masayuki Yamaguchi, et al.. (2019). Characterization of a novel BBB-permeable mutant IDH1 inhibitor, DS-1001b. Annals of Oncology. 30. v145–v146. 2 indexed citations
3.
Nakagawa, Makoto, Takuo Katsumoto, Kazutsune Yamagata, et al.. (2018). Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. Cancer Science. 110(1). 194–208. 20 indexed citations
4.
Ogawara, Yoko, Masayuki Yamaguchi, Yukiko Aikawa, et al.. (2016). The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model. 8.
5.
Ogawara, Yoko, et al.. (2016). Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model. Cancer Research. 76(14_Supplement). 3101–3101. 2 indexed citations
6.
Ogawara, Yoko, Takuo Katsumoto, Yukiko Aikawa, et al.. (2015). IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia. Cancer Research. 75(10). 2005–2016. 45 indexed citations
7.
Ogawara, Yoko, et al.. (2015). The Role of IDH Mutants, Which Are Promising Therapeutic Targets for Acute Myeloid Leukemia. Blood. 126(23). 3796–3796. 1 indexed citations
8.
Ogawara, Yoko & Issay Kitabayashi. (2015). [IDH mutations activate Hoxa9/Meis1 and hypoxia pathways in acute myeloid leukemia model mice].. PubMed. 56(8). 1045–52.
9.
Katsumoto, Takuo, Kazutsune Yamagata, Yoko Ogawara, Takuro Nakamura, & Issay Kitabayashi. (2014). Essential Role of Endogenous MOZ in Aberrant HoxA9 and Meis1 Expressions Induced By MOZ Fusion Gene. Blood. 124(21). 2191–2191. 2 indexed citations
10.
Ogawara, Yoko, Takuo Katsumoto, Yukiko Aikawa, et al.. (2013). Critical Roles Of The IDH2 Mutation In Development and Maintenance Of Acute Myeloid Leukemia. Blood. 122(21). 225–225. 1 indexed citations
11.
Ogawara, Yoko, et al.. (2013). Interactomic approach for evaluating nucleophosmin‐binding proteins as biomarkers for Ewing's sarcoma. Electrophoresis. 34(11). 1670–1678. 9 indexed citations
12.
Ogawara, Yoko, Takuo Katsumoto, Takeshi Uchiumi, Kimitoshi Kohno, & Issay Kitabayashi. (2010). A Critical Role of YB-1 In NPMc-Induced Acute Myeloid Leukemia. Blood. 116(21). 3149–3149. 1 indexed citations
13.
Ogawara, Yoko, Shohei Kishishita, Toshiyuki Obata, et al.. (2002). Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53. Journal of Biological Chemistry. 277(24). 21843–21850. 488 indexed citations
14.
Imai, Tomoya, Yoko Ogawara, Daijiro Ohmori, et al.. (2001). Characterization and Cloning of an Extremely Thermostable, Pyrococcus furiosus-Type 4Fe Ferredoxin from Thermococcus profundus. The Journal of Biochemistry. 130(5). 649–655. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Llorenç Coll-Mulet Breakdown of academic impact, for papers by Anchit Khanna Breakdown of academic impact, for papers by Daniela Di Marcantonio Breakdown of academic impact, for papers by Joji Nakayama Breakdown of academic impact, for papers by Eyal Kalo Breakdown of academic impact, for papers by Susanne Radke Breakdown of academic impact, for papers by Kristin M. Stadelman Breakdown of academic impact, for papers by Kinga A. Kocemba‐Pilarczyk Breakdown of academic impact, for papers by Elena G. Chiorean
Rankless by CCL
2026